These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23615072)

  • 1. Extended haplotype association study in Crohn's disease identifies a novel, Ashkenazi Jewish-specific missense mutation in the NF-κB pathway gene, HEATR3.
    Zhang W; Hui KY; Gusev A; Warner N; Ng SM; Ferguson J; Choi M; Burberry A; Abraham C; Mayer L; Desnick RJ; Cardinale CJ; Hakonarson H; Waterman M; Chowers Y; Karban A; Brant SR; Silverberg MS; Gregersen PK; Katz S; Lifton RP; Zhao H; Nuñez G; Pe'er I; Peter I; Cho JH
    Genes Immun; 2013; 14(5):310-6. PubMed ID: 23615072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews.
    Sugimura K; Taylor KD; Lin YC; Hang T; Wang D; Tang YM; Fischel-Ghodsian N; Targan SR; Rotter JI; Yang H
    Am J Hum Genet; 2003 Mar; 72(3):509-18. PubMed ID: 12577202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease.
    Karban A; Waterman M; Panhuysen CI; Pollak RD; Nesher S; Datta L; Weiss B; Suissa A; Shamir R; Brant SR; Eliakim R
    Am J Gastroenterol; 2004 Jun; 99(6):1134-40. PubMed ID: 15180737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Complexity of Crohn's Disease in Two Large Ashkenazi Jewish Families.
    Levine AP; Pontikos N; Schiff ER; Jostins L; Speed D; ; Lovat LB; Barrett JC; Grasberger H; Plagnol V; Segal AW
    Gastroenterology; 2016 Oct; 151(4):698-709. PubMed ID: 27373512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation at NOD2/CARD15 in familial and sporadic cases of Crohn's disease in the Ashkenazi Jewish population.
    Zhou Z; Lin XY; Akolkar PN; Gulwani-Akolkar B; Levine J; Katz S; Silver J
    Am J Gastroenterol; 2002 Dec; 97(12):3095-101. PubMed ID: 12492195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between mutations in the CARD15 (NOD2) gene and Crohn's disease in Israeli Jewish patients.
    Fidder HH; Olschwang S; Avidan B; Zouali H; Lang A; Bardan E; Picard O; Bar-Meir S; Colombel JF; Chowers Y
    Am J Med Genet A; 2003 Sep; 121A(3):240-4. PubMed ID: 12923865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population.
    Rivas MA; Avila BE; Koskela J; Huang H; Stevens C; Pirinen M; Haritunians T; Neale BM; Kurki M; Ganna A; Graham D; Glaser B; Peter I; Atzmon G; Barzilai N; Levine AP; Schiff E; Pontikos N; Weisburd B; Lek M; Karczewski KJ; Bloom J; Minikel EV; Petersen BS; Beaugerie L; Seksik P; Cosnes J; Schreiber S; Bokemeyer B; Bethge J; ; ; ; Heap G; Ahmad T; Plagnol V; Segal AW; Targan S; Turner D; Saavalainen P; Farkkila M; Kontula K; Palotie A; Brant SR; Duerr RH; Silverberg MS; Rioux JD; Weersma RK; Franke A; Jostins L; Anderson CA; Barrett JC; MacArthur DG; Jalas C; Sokol H; Xavier RJ; Pulver A; Cho JH; McGovern DPB; Daly MJ
    PLoS Genet; 2018 May; 14(5):e1007329. PubMed ID: 29795570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IBD1 locus for susceptibility to Crohn's disease has a greater impact in Ashkenazi Jews with early onset disease.
    Akolkar PN; Gulwani-Akolkar B; Lin XY; Zhou Z; Daly M; Katz S; Levine J; Present D; Gelb B; Desnick R; Mayer L; Silver J
    Am J Gastroenterol; 2001 Apr; 96(4):1127-32. PubMed ID: 11316159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crohn's disease risk alleles on the NOD2 locus have been maintained by natural selection on standing variation.
    Nakagome S; Mano S; Kozlowski L; Bujnicki JM; Shibata H; Fukumaki Y; Kidd JR; Kidd KK; Kawamura S; Oota H
    Mol Biol Evol; 2012 Jun; 29(6):1569-85. PubMed ID: 22319155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study.
    Peter I; Mitchell AA; Ozelius L; Erazo M; Hu J; Doheny D; Abreu MT; Present DH; Ullman T; Benkov K; Korelitz BI; Mayer L; Desnick RJ;
    BMC Med Genet; 2011 May; 12():63. PubMed ID: 21548950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crohn disease: frequency and nature of CARD15 mutations in Ashkenazi and Sephardi/Oriental Jewish families.
    Tukel T; Shalata A; Present D; Rachmilewitz D; Mayer L; Grant D; Risch N; Desnick RJ
    Am J Hum Genet; 2004 Apr; 74(4):623-36. PubMed ID: 15024686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in the IBD5 locus are associated with Crohn disease in pediatric Ashkenazi Jewish patients.
    Tomer G; Wetzler G; Keddache M; Denson LA
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):531-7. PubMed ID: 19412005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci.
    Kenny EE; Pe'er I; Karban A; Ozelius L; Mitchell AA; Ng SM; Erazo M; Ostrer H; Abraham C; Abreu MT; Atzmon G; Barzilai N; Brant SR; Bressman S; Burns ER; Chowers Y; Clark LN; Darvasi A; Doheny D; Duerr RH; Eliakim R; Giladi N; Gregersen PK; Hakonarson H; Jones MR; Marder K; McGovern DP; Mulle J; Orr-Urtreger A; Proctor DD; Pulver A; Rotter JI; Silverberg MS; Ullman T; Warren ST; Waterman M; Zhang W; Bergman A; Mayer L; Katz S; Desnick RJ; Cho JH; Peter I
    PLoS Genet; 2012; 8(3):e1002559. PubMed ID: 22412388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan.
    Bonen DK; Ogura Y; Nicolae DL; Inohara N; Saab L; Tanabe T; Chen FF; Foster SJ; Duerr RH; Brant SR; Cho JH; Nuñez G
    Gastroenterology; 2003 Jan; 124(1):140-6. PubMed ID: 12512038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An SNP linkage scan identifies significant Crohn's disease loci on chromosomes 13q13.3 and, in Jewish families, on 1p35.2 and 3q29.
    Shugart YY; Silverberg MS; Duerr RH; Taylor KD; Wang MH; Zarfas K; Schumm LP; Bromfield G; Steinhart AH; Griffiths AM; Kane SV; Barmada MM; Rotter JI; Mei L; Bernstein CN; Bayless TM; Langelier D; Cohen A; Bitton A; Rioux JD; Cho JH; Brant SR
    Genes Immun; 2008 Mar; 9(2):161-7. PubMed ID: 18246054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GM-CSF.
    Chuang LS; Villaverde N; Hui KY; Mortha A; Rahman A; Levine AP; Haritunians T; Evelyn Ng SM; Zhang W; Hsu NY; Facey JA; Luong T; Fernandez-Hernandez H; Li D; Rivas M; Schiff ER; Gusev A; Schumm LP; Bowen BM; Sharma Y; Ning K; Remark R; Gnjatic S; Legnani P; George J; Sands BE; Stempak JM; Datta LW; Lipka S; Katz S; Cheifetz AS; Barzilai N; Pontikos N; Abraham C; Dubinsky MJ; Targan S; Taylor K; Rotter JI; Scherl EJ; Desnick RJ; Abreu MT; Zhao H; Atzmon G; Pe'er I; Kugathasan S; Hakonarson H; McCauley JL; Lencz T; Darvasi A; Plagnol V; Silverberg MS; Muise AM; Brant SR; Daly MJ; Segal AW; Duerr RH; Merad M; McGovern DP; Peter I; Cho JH
    Gastroenterology; 2016 Oct; 151(4):710-723.e2. PubMed ID: 27377463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.
    Hampe J; Cuthbert A; Croucher PJ; Mirza MM; Mascheretti S; Fisher S; Frenzel H; King K; Hasselmeyer A; MacPherson AJ; Bridger S; van Deventer S; Forbes A; Nikolaus S; Lennard-Jones JE; Foelsch UR; Krawczak M; Lewis C; Schreiber S; Mathew CG
    Lancet; 2001 Jun; 357(9272):1925-8. PubMed ID: 11425413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure to replicate the association of the novel NOD2/CARD15 haplotype (S268P-JW1) to Crohn's disease in the Jewish Israeli population.
    Karban A; Eliakim R
    Gastroenterology; 2004 Feb; 126(2):624-5. PubMed ID: 14765395
    [No Abstract]   [Full Text] [Related]  

  • 19. A genome-wide siRNA screen reveals positive and negative regulators of the NOD2 and NF-κB signaling pathways.
    Warner N; Burberry A; Franchi L; Kim YG; McDonald C; Sartor MA; Núñez G
    Sci Signal; 2013 Jan; 6(258):rs3. PubMed ID: 23322906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA class II alleles associated with susceptibility and resistance to Crohn's disease in the Jewish population.
    Gulwani-Akolkar B; Akolkar PN; Lin XY; Heresbach D; Manji R; Katz S; Yang SY; Silver J
    Inflamm Bowel Dis; 2000 May; 6(2):71-6. PubMed ID: 10833064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.